German
|
English
|
French
Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Search result
- 68609
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Swissmedic Registration
68609
Date of registration
23.12.2022
Company name
Bristol-Myers Squibb SA
Revision date
Valid until
22.12.2027
Indication
Date of market entry
Index Therapeuticus (BSV)
70000.
Revocation Date
Index Therapeuticus (Swissmedic)
07.16.10.
Information for professionals
IP
Seq.-No.
Product
Description
Galenic form
ATC-classification
01
Opdualag (80 mg Relatlimab / 240 mg Nivolumab pro 20 ml)
Konzentrat zur Herstellung einer Infusionslösung
Concentrate for infusion (Relatlimabum 80mg / 20ml, Nivolumabum 240mg / 20ml)
L01FY02
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
